Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease
Clinical trial NCT05725902 · COMPLETED
Trial details
- NCT number
- NCT05725902
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-09
- Primary completion
- 2026-03-09
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.